Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis

In multiple sclerosis, impact of treatment on disability progression can be confounded if treatment also reduces relapses. To distinguish siponimod's direct effects on disability progression from those on relapses in the EXPAND phase 3 trial. Three estimands, one based on principal stratum and...

Celý popis

Podrobná bibliografia

Vydané v:	Multiple sclerosis Ročník 27; číslo 10; s. 1564
Hlavní autori:	Cree, Bruce Ac, Magnusson, Baldur, Rouyrre, Nicolas, Fox, Robert J, Giovannoni, Gavin, Vermersch, Patrick, Bar-Or, Amit, Gold, Ralf, Piani Meier, Daniela, Karlsson, Göril, Tomic, Davorka, Wolf, Christian, Dahlke, Frank, Kappos, Ludwig
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.09.2021
Predmet:	Azetidines - therapeutic use Benzyl Compounds - therapeutic use Disease Progression Humans Multiple Sclerosis, Chronic Progressive - drug therapy Recurrence progression Multiple sclerosis relapses secondary progressive multiple sclerosis progressive multiple sclerosis siponimod
ISSN:	1477-0970, 1477-0970
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!